New! Sign up for our free email newsletter.
Science News
from research organizations

Establishment of induced pluripotent stem cells from Werner syndrome fibroblasts

Date:
November 18, 2014
Source:
Hiroshima University
Summary:
Induced pluripotent stem (iPS) cells from Werner Syndrome fibroblasts have been established, scientists report. The therapeutic methods for this disease are very limited. It is expected that patient-derived iPS cells can be used for the development of innovative therapies. Additionally, the mutated gene in patient-derived iPS cells can be corrected by genome editing. This advantage will be help in the development of new gene and cell therapies for Werner syndrome.
Share:
FULL STORY

Associate Professor Akira Shimamoto and Professor Hidetoshi Tahara at the Graduate School of Biomedical & Health Science in Hiroshima University, Professor Koutaro Yokote at the Graduate School of Medicine in Chiba University, Visiting Professor Makoto Goto at the Medical Center East in Tokyo Women's Medical University, and collaborators including the staff at the Cancer Chemotherapy Center in the Japanese Foundation for Cancer Research, Tottori University, and Keio University established induced pluripotent stem (iPS) cells from the fibroblasts of Werner Syndrome patients. These results were published in PLOS ONE in an article entitled "Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture."

Werner syndrome is characterized by the premature appearance of features associated with normal aging and cancer predisposition. This syndrome occurs frequently in Japan, affecting 1 in 20,000 to 1 in 40,000 people. The therapeutic methods for this disease are very limited and it is expected that iPS cells can be used for the development of innovative therapies.

Dr. Shimamoto and his collaborators analyzed patient-derived iPS cells and found that telomeric abnormalities in the fibroblasts of these patients, which were caused by the lack of WRN helicase encoded by the gene responsible for Werner syndrome, were recovered in the iPS cells generated from these patients. Furthermore, Dr. Shimamoto found that the expression levels of aging-related genes, including those encoding cell cycle inhibitors and inflammatory cytokines, in the patient-derived iPS cells were the same as those in normal iPS cells, even though the expression levels of these genes in the fibroblasts of the patients were higher than those in normal fibroblasts.

Dr. Shimamoto said, "So far, the use of patient cells was restricted to blood or dermal cells in basic research. The iPS cells that we have established will provide an opportunity for drug discovery for the treatment of Werner syndrome and also help with better understanding of the mechanism of this disease. In addition, the mutated WRN gene in patient-derived iPS cells can be corrected by genome editing. This advantage will be help in the development of new gene and cell therapies for Werner syndrome."


Story Source:

Materials provided by Hiroshima University. Note: Content may be edited for style and length.


Journal Reference:

  1. Akira Shimamoto, Harunobu Kagawa, Kazumasa Zensho, Yukihiro Sera, Yasuhiro Kazuki, Mitsuhiko Osaki, Mitsuo Oshimura, Yasuhito Ishigaki, Kanya Hamasaki, Yoshiaki Kodama, Shinsuke Yuasa, Keiichi Fukuda, Kyotaro Hirashima, Hiroyuki Seimiya, Hirofumi Koyama, Takahiko Shimizu, Minoru Takemoto, Koutaro Yokote, Makoto Goto, Hidetoshi Tahara. Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture. PLoS ONE, 2014; 9 (11): e112900 DOI: 10.1371/journal.pone.0112900

Cite This Page:

Hiroshima University. "Establishment of induced pluripotent stem cells from Werner syndrome fibroblasts." ScienceDaily. ScienceDaily, 18 November 2014. <www.sciencedaily.com/releases/2014/11/141118105414.htm>.
Hiroshima University. (2014, November 18). Establishment of induced pluripotent stem cells from Werner syndrome fibroblasts. ScienceDaily. Retrieved October 11, 2024 from www.sciencedaily.com/releases/2014/11/141118105414.htm
Hiroshima University. "Establishment of induced pluripotent stem cells from Werner syndrome fibroblasts." ScienceDaily. www.sciencedaily.com/releases/2014/11/141118105414.htm (accessed October 11, 2024).

Explore More

from ScienceDaily

RELATED STORIES